fluorodeoxyglucose f18 has been researched along with Erythroderma, Sezary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang-Hong, L; Dan, S; Qiang, G; Shu-Xia, W | 1 |
| Attias, D; Polliack, A; Tadmor, T | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Erythroderma, Sezary
| Article | Year |
|---|---|
Preliminary discussion on the value of (18)F-FDG PET/CT in the diagnosis and early staging of non-mycosis fungoides/Sézary's syndrome cutaneous malignant lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Multimodal Imaging; Mycosis Fungoides; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sezary Syndrome; Skin; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Sezary syndrome presenting with tumourous involvement of the breast detected by (18) F-fluorodeoxyglucose positron-emission tomography/computed tomography.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sezary Syndrome; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |